Detailed Physiologic Characterization Reveals Diverse Mechanisms for Novel Genetic Loci Regulating Glucose and Insulin Metabolism in Humans

OBJECTIVE Recent genome-wide association studies have revealed loci associated with glucose and insulin-related traits. We aimed to characterize 19 such loci using detailed measures of insulin processing, secretion, and sensitivity to help elucidate their role in regulation of glucose control, insulin secretion and/or action. RESEARCH DESIGN AND METHODS We investigated associations of loci identified by the Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) with circulating proinsulin, measures of insulin secretion and sensitivity from oral glucose tolerance tests (OGTTs), euglycemic clamps, insulin suppression tests, or frequently sampled intravenous glucose tolerance tests in nondiabetic humans (n = 29,084). RESULTS The glucose-raising allele in MADD was associated with abnormal insulin processing (a dramatic effect on higher proinsulin levels, but no association with insulinogenic index) at extremely persuasive levels of statistical significance (P = 2.1 x 10(-71)). Defects in insulin processing and insulin secretion were seen in glucose-raising allele carriers at TCF7L2, SCL30A8, GIPR, and C2CD4B. Abnormalities in early insulin secretion were suggested in glucose-raising allele carriers at MTNR1B, GCK, FADS1, DGKB, and PROX1 (lower insulinogenic index; no association with proinsulin or insulin sensitivity). Two loci previously associated with fasting insulin (GCKR and IGF1) were associated with OGTT-derived insulin sensitivity indices in a consistent direction. CONCLUSIONS Genetic loci identified through their effect on hyperglycemia and/or hyperinsulinemia demonstrate considerable heterogeneity in associations with measures of insulin processing, secretion, and sensitivity. Our findings emphasize the importance of detailed physiological characterization of such loci for improved understanding of pathways associated with alterations in glucose homeostasis and eventually type 2 diabetes.

Citing Articles

Associations Between TCF7L2, PPARγ, and KCNJ11 Genotypes and Insulin Response to an Oral Glucose Tolerance Test: A Systematic Review.

Blanken C, Bayer S, Buchner Carro S, Hauner H, Holzapfel C Mol Nutr Food Res. 2025; 69(3):e202400561.

PMID: 39828593 PMC: 11791742. DOI: 10.1002/mnfr.202400561.

Cross-sectional, interventional, and causal investigation of insulin sensitivity using plasma proteomics in diverse populations.

Kho P, Wary N, Zanetti D, Abbasi F, Knowles J, Panyard D medRxiv. 2024; .

PMID: 39606342 PMC: 11601714. DOI: 10.1101/2024.11.09.24317011.

Genetic architecture of oral glucose-stimulated insulin release provides biological insights into type 2 diabetes aetiology.

Madsen A, Bonas-Guarch S, Gheibi S, Prasad R, Vangipurapu J, Ahuja V Nat Metab. 2024; 6(10):1897-1912.

PMID: 39420167 PMC: 11496110. DOI: 10.1038/s42255-024-01140-6.

A splice site variant in MADD affects hormone expression in pancreatic β cells and pituitary gonadotropes.

Pulli K, Saarimaki-Vire J, Ahonen P, Liu X, Ibrahim H, Chandra V JCI Insight. 2024; 9(10).

PMID: 38775154 PMC: 11141940. DOI: 10.1172/jci.insight.167598.

C2CD4B Evokes Oxidative Stress and Vascular Dysfunction via a PI3K/Akt/PKCα-Signaling Pathway.

Di Pietro P, Abate A, Prete V, Damato A, Venturini E, Rusciano M Antioxidants (Basel). 2024; 13(1).

PMID: 38247525 PMC: 10812653. DOI: 10.3390/antiox13010101.

References

Hanley A, DAgostino Jr R, Wagenknecht L, Saad M, Savage P, Bergman R . Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study. Diabetes. 2002; 51(4):1263-70. DOI: 10.2337/diabetes.51.4.1263. View

Kurada B, Li L, Mulherkar N, Subramanian M, Prasad K, Prabhakar B . MADD, a splice variant of IG20, is indispensable for MAPK activation and protection against apoptosis upon tumor necrosis factor-alpha treatment. J Biol Chem. 2009; 284(20):13533-13541. PMC: 2679454. DOI: 10.1074/jbc.M808554200. View

Bell G, Polonsky K . Diabetes mellitus and genetically programmed defects in beta-cell function. Nature. 2001; 414(6865):788-91. DOI: 10.1038/414788a. View

Holst J, Gromada J . Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. Am J Physiol Endocrinol Metab. 2004; 287(2):E199-206. DOI: 10.1152/ajpendo.00545.2003. View

Christiansen E, Schnider S, Palmvig B, Pedersen O . Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM. Diabetes Care. 1997; 20(5):881-7. DOI: 10.2337/diacare.20.5.881. View

Staiger H, Machicao F, Schafer S, Kirchhoff K, Kantartzis K, Guthoff M . Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function. PLoS One. 2008; 3(12):e3962. PMC: 2597741. DOI: 10.1371/journal.pone.0003962. View

Saxena R, Hivert M, Langenberg C, Tanaka T, Pankow J, Vollenweider P . Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet. 2010; 42(2):142-8. PMC: 2922003. DOI: 10.1038/ng.521. View

Gieger C, Geistlinger L, Altmaier E, de Angelis M, Kronenberg F, Meitinger T . Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet. 2008; 4(11):e1000282. PMC: 2581785. DOI: 10.1371/journal.pgen.1000282. View

Matsuda M, DeFronzo R . Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999; 22(9):1462-70. DOI: 10.2337/diacare.22.9.1462. View

10.

Li X, Shu Y, Xiang A, Trigo E, Kuusisto J, Hartiala J . Additive effects of genetic variation in GCK and G6PC2 on insulin secretion and fasting glucose. Diabetes. 2009; 58(12):2946-53. PMC: 2780888. DOI: 10.2337/db09-0228. View

11.

Meier J, Hucking K, Holst J, Deacon C, Schmiegel W, Nauck M . Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes. Diabetes. 2001; 50(11):2497-504. DOI: 10.2337/diabetes.50.11.2497. View

12.

Byrne C, Wareham N, Brown D, Clark P, Cox L, Day N . Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids. Diabetologia. 1994; 37(9):889-96. DOI: 10.1007/BF00400944. View

13.

Chimienti F, Devergnas S, Pattou F, Schuit F, Garcia-Cuenca R, Vandewalle B . In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J Cell Sci. 2006; 119(Pt 20):4199-206. DOI: 10.1242/jcs.03164. View

14.

Marchini J, Howie B, Myers S, McVean G, Donnelly P . A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet. 2007; 39(7):906-13. DOI: 10.1038/ng2088. View

15.

Velho G, Froguel P, Clement K, Pueyo M, Rakotoambinina B, Zouali H . Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet. 1992; 340(8817):444-8. DOI: 10.1016/0140-6736(92)91768-4. View

16.

Taylor K, Nicholson R . The LZT proteins; the LIV-1 subfamily of zinc transporters. Biochim Biophys Acta. 2003; 1611(1-2):16-30. DOI: 10.1016/s0005-2736(03)00048-8. View

17.

Frigerio G, Grimsey N, Dale M, Majoul I, Duden R . Two human ARFGAPs associated with COP-I-coated vesicles. Traffic. 2007; 8(11):1644-55. PMC: 2171037. DOI: 10.1111/j.1600-0854.2007.00631.x. View

18.

Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, van Haeften T . Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care. 2000; 23(3):295-301. DOI: 10.2337/diacare.23.3.295. View

19.

Tura A, Kautzky-Willer A, Pacini G . Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT. Diabetes Res Clin Pract. 2005; 72(3):298-301. DOI: 10.1016/j.diabres.2005.10.005. View

20.

Pareja A, Tinahones F, Soriguer F, Monzon A, Esteva de Antonio I, Garcia-Arnes J . Unsaturated fatty acids alter the insulin secretion response of the islets of Langerhans in vitro. Diabetes Res Clin Pract. 1998; 38(3):143-9. DOI: 10.1016/s0168-8227(97)00103-4. View